APO RESEARCH · REPORT
Hyaluronic Acid-based Biomaterials
Hyaluronic acid-based biomaterials, is a carbohydrate, more specifically a mucopolysaccharide occurring naturally throughout the human body. It is found in the highest concentrations in fluids in the eyes and joints. It has been used in a wide range of orthopedic injections, ophthalmic solutions, viscoelastic injections for ophthalmic surgery, cosmetic fillers, surgical anti-adhesion products, skin care products and food supplements.
Product & engineering
Understand the product.
Hyaluronic acid-based biomaterials, is a carbohydrate, more specifically a mucopolysaccharide occurring naturally throughout the human body. It is found in the highest concentrations in fluids in the eyes and joints. It has been used in a wide range of orthopedic injections, ophthalmic solutions, viscoelastic injections for ophthalmic surgery, cosmetic fillers, surgical anti-adhesion products, skin care products and food supplements.
Common commercially available hyaluronic acid-based biomaterials are mainly hyaluronic acid. Hyaluronic acid (HA) is known as hyaluronan or hyaluronate. In this report, the volume of hyaluronic acid-based biomaterials is calculated by pure hyaluronic acid powder.
Selected research
Industry Research
Hyaluronic Acid-based Biomaterials Industry Research Report 2026
Market perspective
Hyaluronic acid-based biomaterials, is a carbohydrate, more specifically a mucopolysaccharide occurring naturally throughout the human body. It is found in the highest concentrations in fluids in the eyes and joints. It has been used in a wide range of orthopedic injections, ophthalmic solutions, viscoelastic injections for ophthalmic surgery, cosmetic fillers, surgical anti-adhesion products, skin care products and food supplements.
Common commercially available hyaluronic acid-based biomaterials are mainly hyaluronic acid. Hyaluronic acid (HA) is known as hyaluronan or hyaluronate. In this report, the volume of hyaluronic acid-based biomaterials is calculated by pure hyaluronic acid powder.
The major manufacturers of Hyaluronic Acid-based Biomaterials are concentrated in Bloomage BioTechnology, Shandong Galaxy Bio-Tech, Kewpie, CPN, China Eastar and FocusChem Biotech. Bloomage BioTechnology is the world leader, holding 42% production market share.
Read the full market overview
In the consumption market, China is the largest consumption market. The consumption share of China is 27%.
Report Scope
This report quantifies the global Hyaluronic Acid-based Biomaterials market in revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Hyaluronic Acid-based Biomaterials.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hyaluronic Acid-based Biomaterials Market by Company
Kewpie
CPN
Shiseido
Novozymes
Bloomage BioTechnology
Shandong Galaxy Bio-Tech
China Eastar
FocusChem Biotech
Shandong Topscience Biotech
QuFu GuangLong Biochem
Weifang Lide Bioengineering
Jiangsu Haihua Biotech
Qufu Liyang Biochem Industrial
Tongxiang Hengji biotechnology
Hyaluronic Acid-based Biomaterials Segment by Type
Cosmetic Grade
Food Grade
Pharmaceutical Grade
Hyaluronic Acid-based Biomaterials Segment by Application
Medical Hygiene
Plastic Surgery
Health Products
Cosmetic
Hyaluronic Acid-based Biomaterials Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hyaluronic Acid-based Biomaterials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hyaluronic Acid-based Biomaterials and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hyaluronic Acid-based Biomaterials.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hyaluronic Acid-based Biomaterials manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hyaluronic Acid-based Biomaterials by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hyaluronic Acid-based Biomaterials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cosmetic Grade
- Food Grade
- Pharmaceutical Grade
Applications
- Medical Hygiene
- Plastic Surgery
- Health Products
- Cosmetic
Companies covered
- Kewpie
- CPN
- Shiseido
- Novozymes
- Bloomage BioTechnology
- Shandong Galaxy Bio-Tech
- China Eastar
- FocusChem Biotech
- Shandong Topscience Biotech
- QuFu GuangLong Biochem
- Weifang Lide Bioengineering
- Jiangsu Haihua Biotech
- Qufu Liyang Biochem Industrial
- Tongxiang Hengji biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Hyaluronic Acid-based Biomaterials by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Cosmetic Grade
- 2.2.3 Food Grade
- 2.2.4 Pharmaceutical Grade
- 2.3 Hyaluronic Acid-based Biomaterials by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Medical Hygiene
- 2.3.3 Plastic Surgery
- 2.3.4 Health Products
- 2.3.5 Cosmetic
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Hyaluronic Acid-based Biomaterials Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Hyaluronic Acid-based Biomaterials Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Hyaluronic Acid-based Biomaterials Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Hyaluronic Acid-based Biomaterials Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hyaluronic Acid-based Biomaterials Production by Manufacturers (2021-2026)
- 3.2 Global Hyaluronic Acid-based Biomaterials Production Value by Manufacturers (2021-2026)
- 3.3 Global Hyaluronic Acid-based Biomaterials Average Price by Manufacturers (2021-2026)
- 3.4 Global Hyaluronic Acid-based Biomaterials Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Hyaluronic Acid-based Biomaterials Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Hyaluronic Acid-based Biomaterials Manufacturers, Product Type & Application
- 3.7 Global Hyaluronic Acid-based Biomaterials Manufacturers Established Date
- 3.8 Global Hyaluronic Acid-based Biomaterials Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Kewpie
- 4.1.1 Kewpie Hyaluronic Acid-based Biomaterials Company Information
- 4.1.2 Kewpie Hyaluronic Acid-based Biomaterials Business Overview
- 4.1.3 Kewpie Hyaluronic Acid-based Biomaterials Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Kewpie Product Portfolio
- 4.1.5 Kewpie Recent Developments
- 4.2 CPN
- 4.2.1 CPN Hyaluronic Acid-based Biomaterials Company Information
- 4.2.2 CPN Hyaluronic Acid-based Biomaterials Business Overview
- 4.2.3 CPN Hyaluronic Acid-based Biomaterials Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 CPN Product Portfolio
- 4.2.5 CPN Recent Developments
- 4.3 Shiseido
- 4.3.1 Shiseido Hyaluronic Acid-based Biomaterials Company Information
- 4.3.2 Shiseido Hyaluronic Acid-based Biomaterials Business Overview
- 4.3.3 Shiseido Hyaluronic Acid-based Biomaterials Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Shiseido Product Portfolio
- 4.3.5 Shiseido Recent Developments
- 4.4 Novozymes
- 4.4.1 Novozymes Hyaluronic Acid-based Biomaterials Company Information
- 4.4.2 Novozymes Hyaluronic Acid-based Biomaterials Business Overview
- 4.4.3 Novozymes Hyaluronic Acid-based Biomaterials Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Novozymes Product Portfolio
- 4.4.5 Novozymes Recent Developments
- 4.5 Bloomage BioTechnology
- 4.5.1 Bloomage BioTechnology Hyaluronic Acid-based Biomaterials Company Information
- 4.5.2 Bloomage BioTechnology Hyaluronic Acid-based Biomaterials Business Overview
- 4.5.3 Bloomage BioTechnology Hyaluronic Acid-based Biomaterials Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Bloomage BioTechnology Product Portfolio
- 4.5.5 Bloomage BioTechnology Recent Developments
- 4.6 Shandong Galaxy Bio-Tech
- 4.6.1 Shandong Galaxy Bio-Tech Hyaluronic Acid-based Biomaterials Company Information
- 4.6.2 Shandong Galaxy Bio-Tech Hyaluronic Acid-based Biomaterials Business Overview
- 4.6.3 Shandong Galaxy Bio-Tech Hyaluronic Acid-based Biomaterials Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Shandong Galaxy Bio-Tech Product Portfolio
- 4.6.5 Shandong Galaxy Bio-Tech Recent Developments
- 4.7 China Eastar
- 4.7.1 China Eastar Hyaluronic Acid-based Biomaterials Company Information
- 4.7.2 China Eastar Hyaluronic Acid-based Biomaterials Business Overview
- 4.7.3 China Eastar Hyaluronic Acid-based Biomaterials Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 China Eastar Product Portfolio
- 4.7.5 China Eastar Recent Developments
- 4.8 FocusChem Biotech
- 4.8.1 FocusChem Biotech Hyaluronic Acid-based Biomaterials Company Information
- 4.8.2 FocusChem Biotech Hyaluronic Acid-based Biomaterials Business Overview
- 4.8.3 FocusChem Biotech Hyaluronic Acid-based Biomaterials Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 FocusChem Biotech Product Portfolio
- 4.8.5 FocusChem Biotech Recent Developments
- 4.9 Shandong Topscience Biotech
- 4.9.1 Shandong Topscience Biotech Hyaluronic Acid-based Biomaterials Company Information
- 4.9.2 Shandong Topscience Biotech Hyaluronic Acid-based Biomaterials Business Overview
- 4.9.3 Shandong Topscience Biotech Hyaluronic Acid-based Biomaterials Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Shandong Topscience Biotech Product Portfolio
- 4.9.5 Shandong Topscience Biotech Recent Developments
- 4.10 QuFu GuangLong Biochem
- 4.10.1 QuFu GuangLong Biochem Hyaluronic Acid-based Biomaterials Company Information
- 4.10.2 QuFu GuangLong Biochem Hyaluronic Acid-based Biomaterials Business Overview
- 4.10.3 QuFu GuangLong Biochem Hyaluronic Acid-based Biomaterials Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 QuFu GuangLong Biochem Product Portfolio
- 4.10.5 QuFu GuangLong Biochem Recent Developments
- 4.11 Weifang Lide Bioengineering
- 4.11.1 Weifang Lide Bioengineering Hyaluronic Acid-based Biomaterials Company Information
- 4.11.2 Weifang Lide Bioengineering Hyaluronic Acid-based Biomaterials Business Overview
- 4.11.3 Weifang Lide Bioengineering Hyaluronic Acid-based Biomaterials Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Weifang Lide Bioengineering Product Portfolio
- 4.11.5 Weifang Lide Bioengineering Recent Developments
- 4.12 Jiangsu Haihua Biotech
- 4.12.1 Jiangsu Haihua Biotech Hyaluronic Acid-based Biomaterials Company Information
- 4.12.2 Jiangsu Haihua Biotech Hyaluronic Acid-based Biomaterials Business Overview
- 4.12.3 Jiangsu Haihua Biotech Hyaluronic Acid-based Biomaterials Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Jiangsu Haihua Biotech Product Portfolio
- 4.12.5 Jiangsu Haihua Biotech Recent Developments
- 4.13 Qufu Liyang Biochem Industrial
- 4.13.1 Qufu Liyang Biochem Industrial Hyaluronic Acid-based Biomaterials Company Information
- 4.13.2 Qufu Liyang Biochem Industrial Hyaluronic Acid-based Biomaterials Business Overview
- 4.13.3 Qufu Liyang Biochem Industrial Hyaluronic Acid-based Biomaterials Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 Qufu Liyang Biochem Industrial Product Portfolio
- 4.13.5 Qufu Liyang Biochem Industrial Recent Developments
- 4.14 Tongxiang Hengji biotechnology
- 4.14.1 Tongxiang Hengji biotechnology Hyaluronic Acid-based Biomaterials Company Information
- 4.14.2 Tongxiang Hengji biotechnology Hyaluronic Acid-based Biomaterials Business Overview
- 4.14.3 Tongxiang Hengji biotechnology Hyaluronic Acid-based Biomaterials Production Capacity, Value and Gross Margin (2021-2026)
- 4.14.4 Tongxiang Hengji biotechnology Product Portfolio
- 4.14.5 Tongxiang Hengji biotechnology Recent Developments
5 Global Hyaluronic Acid-based Biomaterials Production by Region
- 5.1 Global Hyaluronic Acid-based Biomaterials Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hyaluronic Acid-based Biomaterials Production by Region: 2021-2032
- 5.2.1 Global Hyaluronic Acid-based Biomaterials Production by Region: 2021-2026
- 5.2.2 Global Hyaluronic Acid-based Biomaterials Production Forecast by Region (2027-2032)
- 5.3 Global Hyaluronic Acid-based Biomaterials Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Hyaluronic Acid-based Biomaterials Production Value by Region: 2021-2032
- 5.4.1 Global Hyaluronic Acid-based Biomaterials Production Value by Region: 2021-2026
- 5.4.2 Global Hyaluronic Acid-based Biomaterials Production Value Forecast by Region (2027-2032)
- 5.5 Global Hyaluronic Acid-based Biomaterials Market Price Analysis by Region (2021-2026)
- 5.6 Global Hyaluronic Acid-based Biomaterials Production and Value, YOY Growth
- 5.6.1 North America Hyaluronic Acid-based Biomaterials Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Hyaluronic Acid-based Biomaterials Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Hyaluronic Acid-based Biomaterials Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Hyaluronic Acid-based Biomaterials Production Value Estimates and Forecasts (2021-2032)
6 Global Hyaluronic Acid-based Biomaterials Consumption by Region
- 6.1 Global Hyaluronic Acid-based Biomaterials Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Hyaluronic Acid-based Biomaterials Consumption by Region (2021-2032)
- 6.2.1 Global Hyaluronic Acid-based Biomaterials Consumption by Region: 2021-2026
- 6.2.2 Global Hyaluronic Acid-based Biomaterials Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Hyaluronic Acid-based Biomaterials Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Hyaluronic Acid-based Biomaterials Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Hyaluronic Acid-based Biomaterials Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Hyaluronic Acid-based Biomaterials Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Hyaluronic Acid-based Biomaterials Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Hyaluronic Acid-based Biomaterials Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Hyaluronic Acid-based Biomaterials Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Hyaluronic Acid-based Biomaterials Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Hyaluronic Acid-based Biomaterials Production by Type (2021-2032)
- 7.1.1 Global Hyaluronic Acid-based Biomaterials Production by Type (2021-2032) & (MT)
- 7.1.2 Global Hyaluronic Acid-based Biomaterials Production Market Share by Type (2021-2032)
- 7.2 Global Hyaluronic Acid-based Biomaterials Production Value by Type (2021-2032)
- 7.2.1 Global Hyaluronic Acid-based Biomaterials Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Hyaluronic Acid-based Biomaterials Production Value Market Share by Type (2021-2032)
- 7.3 Global Hyaluronic Acid-based Biomaterials Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Hyaluronic Acid-based Biomaterials Production by Application (2021-2032)
- 8.1.1 Global Hyaluronic Acid-based Biomaterials Production by Application (2021-2032) & (MT)
- 8.1.2 Global Hyaluronic Acid-based Biomaterials Production Market Share by Application (2021-2032)
- 8.2 Global Hyaluronic Acid-based Biomaterials Production Value by Application (2021-2032)
- 8.2.1 Global Hyaluronic Acid-based Biomaterials Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Hyaluronic Acid-based Biomaterials Production Value Market Share by Application (2021-2032)
- 8.3 Global Hyaluronic Acid-based Biomaterials Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Hyaluronic Acid-based Biomaterials Value Chain Analysis
- 9.1.1 Hyaluronic Acid-based Biomaterials Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Hyaluronic Acid-based Biomaterials Production Mode & Process
- 9.2 Hyaluronic Acid-based Biomaterials Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Hyaluronic Acid-based Biomaterials Distributors
- 9.2.3 Hyaluronic Acid-based Biomaterials Customers
10 Global Hyaluronic Acid-based Biomaterials Analyzing Market Dynamics
- 10.1 Hyaluronic Acid-based Biomaterials Industry Trends
- 10.2 Hyaluronic Acid-based Biomaterials Industry Drivers
- 10.3 Hyaluronic Acid-based Biomaterials Industry Opportunities and Challenges
- 10.4 Hyaluronic Acid-based Biomaterials Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst